Requirements for DXA for the management of osteoporosis in Europe View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-12-24

AUTHORS

J. A. Kanis, O. Johnell

ABSTRACT

The availability of dual energy X-ray absorptiometry (DXA) varies markedly in different countries. There is, however, little information to indicate the optimal requirements for this technology. The principal aim of this study was to estimate the requirements for DXA in Europe for the assessment and treatment of osteoporosis. Three assessment scenarios were chosen. The first envisaged screening of all women with DXA at the age of 65 years. A second scenario comprised a screening programme based on the identification of clinical risk factors with the selective addition of BMD tests in those close to an intervention threshold. The third scenario envisaged a case finding strategy where women aged 65 years were identified on the basis of risk factors and referred for DXA. Requirements for women aged more than 65 years were amortised over a 10-year period. A secondary aim was to estimate the number and cost of osteoporotic fractures in Europe. The requirements for DXA in assessment ranged from 4.21 to 11.21 units/million of the population. The most efficient assessment scenario was the use of clinical risk factors with the selective use of BMD. With this scenario, an additional 6.39 units/million would be required to monitor treatment giving a total requirement of 10.6 units/million. In 2000, the number of osteoporotic fractures was estimated at 3.79 million, of which 0.89 million were hip fractures (179,000 hip fractures in men and 711,000 in women). The total direct costs were estimated at €31.7 billion (£21.165 billion), which were expected to increase to €76.7 billion (£51.1 billion) in 2050 based on the expected changes in the demography of Europe. More... »

PAGES

229-238

References to SciGraph publications

  • 2001-05. The Burden of Osteoporotic Fractures: A Method for Setting Intervention Thresholds in OSTEOPOROSIS INTERNATIONAL
  • 2004-02-18. Action Plan for the prevention of osteoporotic fractures in the European Community in OSTEOPOROSIS INTERNATIONAL
  • 2004-07-01. The burden of hospitalised fractures in Sweden in OSTEOPOROSIS INTERNATIONAL
  • 2004-04-22. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden in OSTEOPOROSIS INTERNATIONAL
  • 2000-09. Long-Term Risk of Osteoporotic Fracture in Malmö in OSTEOPOROSIS INTERNATIONAL
  • 2003-11-04. Two new regions of interest to evaluate separately cortical and trabecular BMD in the proximal femur using DXA in OSTEOPOROSIS INTERNATIONAL
  • 2003-04-01. Cost-equivalence of different osteoporotic fractures in OSTEOPOROSIS INTERNATIONAL
  • 1999-01. Fracture Incidence in Olmsted County, Minnesota: Comparison of Urban with Rural Rates and Changes in Urban Rates Over time in OSTEOPOROSIS INTERNATIONAL
  • 1997-03. The hospital burden of vertebral fracture in Europe: A study of national register sources in OSTEOPOROSIS INTERNATIONAL
  • 1992-11. The apparent incidence of hip fracture in Europe: A study of national register sources in OSTEOPOROSIS INTERNATIONAL
  • 1998-11. The Cost of Treating Osteoporotic Fractures in the United Kingdom Female Population in OSTEOPOROSIS INTERNATIONAL
  • 2003-11-13. Undertreatment with anti-osteoporotic drugs after hospitalization for fracture in OSTEOPOROSIS INTERNATIONAL
  • 2003-04-30. The hospital cost of vertebral fractures in the EU: estimates using national datasets in OSTEOPOROSIS INTERNATIONAL
  • 1997-07. Guidelines for diagnosis and management of osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 1994-09. The variable incidence of hip fracture in Southern Europe: The MEDOS study in OSTEOPOROSIS INTERNATIONAL
  • 2003-10-31. The risk and burden of vertebral fractures in Sweden in OSTEOPOROSIS INTERNATIONAL
  • 1997-09. World-wide Projections for Hip Fracture in OSTEOPOROSIS INTERNATIONAL
  • 2000-03. An Update on the Diagnosis and Assessment of Osteoporosis with Densitometry in OSTEOPOROSIS INTERNATIONAL
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00198-004-1811-2

    DOI

    http://dx.doi.org/10.1007/s00198-004-1811-2

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1033148553

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/15618996


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Absorptiometry, Photon", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Age Distribution", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bone Density", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cost-Benefit Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Europe", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hip Fractures", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mass Screening", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Osteoporosis, Postmenopausal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Patient Selection", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Risk Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sex Distribution", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK", 
              "id": "http://www.grid.ac/institutes/grid.11835.3e", 
              "name": [
                "WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kanis", 
            "givenName": "J. A.", 
            "id": "sg:person.0663427426.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663427426.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Orthopaedics, Malmo General Hospital, S-214 01, Malmo, Sweden", 
              "id": "http://www.grid.ac/institutes/grid.411843.b", 
              "name": [
                "Department of Orthopaedics, Malmo General Hospital, S-214 01, Malmo, Sweden"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Johnell", 
            "givenName": "O.", 
            "id": "sg:person.01045771226.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045771226.52"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00198-004-1605-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009573377", 
              "https://doi.org/10.1007/s00198-004-1605-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-003-1463-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049023520", 
              "https://doi.org/10.1007/s00198-003-1463-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-003-1385-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020641858", 
              "https://doi.org/10.1007/s00198-003-1385-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980050113", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027556556", 
              "https://doi.org/10.1007/s001980050113"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01623782", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015221140", 
              "https://doi.org/10.1007/bf01623782"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980050281", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008829241", 
              "https://doi.org/10.1007/s001980050281"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-003-1500-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024649739", 
              "https://doi.org/10.1007/s00198-003-1500-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980170112", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037984736", 
              "https://doi.org/10.1007/s001980170112"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-003-1544-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029733134", 
              "https://doi.org/10.1007/s00198-003-1544-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01623349", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002170955", 
              "https://doi.org/10.1007/bf01623349"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-004-1623-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048606247", 
              "https://doi.org/10.1007/s00198-004-1623-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01623186", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017480562", 
              "https://doi.org/10.1007/bf01623186"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/pl00004148", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016444239", 
              "https://doi.org/10.1007/pl00004148"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-004-1686-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016570955", 
              "https://doi.org/10.1007/s00198-004-1686-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980050107", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004873970", 
              "https://doi.org/10.1007/s001980050107"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001980070064", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042388661", 
              "https://doi.org/10.1007/s001980070064"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01623689", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019441113", 
              "https://doi.org/10.1007/bf01623689"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00198-003-1395-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016850751", 
              "https://doi.org/10.1007/s00198-003-1395-2"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2004-12-24", 
        "datePublishedReg": "2004-12-24", 
        "description": "The availability of dual energy X-ray absorptiometry (DXA) varies markedly in different countries. There is, however, little information to indicate the optimal requirements for this technology. The principal aim of this study was to estimate the requirements for DXA in Europe for the assessment and treatment of osteoporosis. Three assessment scenarios were chosen. The first envisaged screening of all women with DXA at the age of 65 years. A second scenario comprised a screening programme based on the identification of clinical risk factors with the selective addition of BMD tests in those close to an intervention threshold. The third scenario envisaged a case finding strategy where women aged 65 years were identified on the basis of risk factors and referred for DXA. Requirements for women aged more than 65 years were amortised over a 10-year period. A secondary aim was to estimate the number and cost of osteoporotic fractures in Europe. The requirements for DXA in assessment ranged from 4.21 to 11.21 units/million of the population. The most efficient assessment scenario was the use of clinical risk factors with the selective use of BMD. With this scenario, an additional 6.39 units/million would be required to monitor treatment giving a total requirement of 10.6 units/million. In 2000, the number of osteoporotic fractures was estimated at 3.79 million, of which 0.89 million were hip fractures (179,000 hip fractures in men and 711,000 in women). The total direct costs were estimated at \u20ac31.7 billion (\u00a321.165 billion), which were expected to increase to \u20ac76.7 billion (\u00a351.1 billion) in 2050 based on the expected changes in the demography of Europe.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00198-004-1811-2", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1100834", 
            "issn": [
              "0937-941X", 
              "1433-2965"
            ], 
            "name": "Osteoporosis International", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "16"
          }
        ], 
        "keywords": [
          "clinical risk factors", 
          "risk factors", 
          "osteoporotic fractures", 
          "management of osteoporosis", 
          "treatment of osteoporosis", 
          "total direct costs", 
          "dual energy X", 
          "hip fracture", 
          "BMD test", 
          "screening program", 
          "ray absorptiometry", 
          "secondary aim", 
          "intervention threshold", 
          "DXA", 
          "direct costs", 
          "energy X", 
          "women", 
          "osteoporosis", 
          "selective use", 
          "treatment", 
          "little information", 
          "fractures", 
          "years", 
          "aim", 
          "absorptiometry", 
          "BMD", 
          "factors", 
          "optimal requirements", 
          "total requirement", 
          "assessment", 
          "age", 
          "screening", 
          "population", 
          "use", 
          "different countries", 
          "period", 
          "management", 
          "principal aim", 
          "study", 
          "cases", 
          "number", 
          "millions", 
          "test", 
          "changes", 
          "assessment scenarios", 
          "threshold", 
          "program", 
          "identification", 
          "addition", 
          "strategies", 
          "Europe", 
          "countries", 
          "availability", 
          "information", 
          "cost", 
          "basis", 
          "requirements", 
          "demography", 
          "selective addition", 
          "scenarios", 
          "third scenario", 
          "technology", 
          "second scenario"
        ], 
        "name": "Requirements for DXA for the management of osteoporosis in Europe", 
        "pagination": "229-238", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1033148553"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00198-004-1811-2"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "15618996"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00198-004-1811-2", 
          "https://app.dimensions.ai/details/publication/pub.1033148553"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:22", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_380.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00198-004-1811-2"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-004-1811-2'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-004-1811-2'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-004-1811-2'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-004-1811-2'


     

    This table displays all metadata directly associated to this object as RDF triples.

    275 TRIPLES      22 PREDICATES      124 URIs      97 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00198-004-1811-2 schema:about N0dd6a5f1212d4ef89b645305379b4b7f
    2 N0f86bfe3513d49048f87a947dcc77062
    3 N1ac92e67f401422ea98eb9008240796c
    4 N2ac417c8c0694b709b3e6719561c0b14
    5 N3d778d3b5a09491988c8a516fcb9cc63
    6 N56a7ffa941a1458b8749731f7e201d80
    7 N65bc4aeff20e489dae590225bcc63f84
    8 N6c0bdf54e9cb41f6bd59fb77b2588be0
    9 N6c58d8d179874a4d94a4b2ca912b5d99
    10 N7aa9963c1a984254ac8f732dd211d5fd
    11 Nb0bfbfc5a9d1443095bc15a9493c0600
    12 Nd6a711a8ad3d4aaeab487b1e5f7d505a
    13 Ndae2714d33ac4d72b9c66732524d7404
    14 Ndca4bba4df1b44b88964500acf6d7490
    15 Nf10306a0e1a74fa8aa03292bf6066786
    16 Nf3948982199e436ea893721a1619d158
    17 anzsrc-for:11
    18 anzsrc-for:1103
    19 anzsrc-for:1117
    20 schema:author Na5df5f249b88477dad9613fa5bfe88e6
    21 schema:citation sg:pub.10.1007/bf01623186
    22 sg:pub.10.1007/bf01623349
    23 sg:pub.10.1007/bf01623689
    24 sg:pub.10.1007/bf01623782
    25 sg:pub.10.1007/pl00004148
    26 sg:pub.10.1007/s00198-003-1385-4
    27 sg:pub.10.1007/s00198-003-1395-2
    28 sg:pub.10.1007/s00198-003-1463-7
    29 sg:pub.10.1007/s00198-003-1500-6
    30 sg:pub.10.1007/s00198-003-1544-7
    31 sg:pub.10.1007/s00198-004-1605-6
    32 sg:pub.10.1007/s00198-004-1623-4
    33 sg:pub.10.1007/s00198-004-1686-2
    34 sg:pub.10.1007/s001980050107
    35 sg:pub.10.1007/s001980050113
    36 sg:pub.10.1007/s001980050281
    37 sg:pub.10.1007/s001980070064
    38 sg:pub.10.1007/s001980170112
    39 schema:datePublished 2004-12-24
    40 schema:datePublishedReg 2004-12-24
    41 schema:description The availability of dual energy X-ray absorptiometry (DXA) varies markedly in different countries. There is, however, little information to indicate the optimal requirements for this technology. The principal aim of this study was to estimate the requirements for DXA in Europe for the assessment and treatment of osteoporosis. Three assessment scenarios were chosen. The first envisaged screening of all women with DXA at the age of 65 years. A second scenario comprised a screening programme based on the identification of clinical risk factors with the selective addition of BMD tests in those close to an intervention threshold. The third scenario envisaged a case finding strategy where women aged 65 years were identified on the basis of risk factors and referred for DXA. Requirements for women aged more than 65 years were amortised over a 10-year period. A secondary aim was to estimate the number and cost of osteoporotic fractures in Europe. The requirements for DXA in assessment ranged from 4.21 to 11.21 units/million of the population. The most efficient assessment scenario was the use of clinical risk factors with the selective use of BMD. With this scenario, an additional 6.39 units/million would be required to monitor treatment giving a total requirement of 10.6 units/million. In 2000, the number of osteoporotic fractures was estimated at 3.79 million, of which 0.89 million were hip fractures (179,000 hip fractures in men and 711,000 in women). The total direct costs were estimated at €31.7 billion (£21.165 billion), which were expected to increase to €76.7 billion (£51.1 billion) in 2050 based on the expected changes in the demography of Europe.
    42 schema:genre article
    43 schema:inLanguage en
    44 schema:isAccessibleForFree false
    45 schema:isPartOf N343fc081b70740ad97789dabb7fc8867
    46 Nd73016a883644eee9d0ecb4607c3ee48
    47 sg:journal.1100834
    48 schema:keywords BMD
    49 BMD test
    50 DXA
    51 Europe
    52 absorptiometry
    53 addition
    54 age
    55 aim
    56 assessment
    57 assessment scenarios
    58 availability
    59 basis
    60 cases
    61 changes
    62 clinical risk factors
    63 cost
    64 countries
    65 demography
    66 different countries
    67 direct costs
    68 dual energy X
    69 energy X
    70 factors
    71 fractures
    72 hip fracture
    73 identification
    74 information
    75 intervention threshold
    76 little information
    77 management
    78 management of osteoporosis
    79 millions
    80 number
    81 optimal requirements
    82 osteoporosis
    83 osteoporotic fractures
    84 period
    85 population
    86 principal aim
    87 program
    88 ray absorptiometry
    89 requirements
    90 risk factors
    91 scenarios
    92 screening
    93 screening program
    94 second scenario
    95 secondary aim
    96 selective addition
    97 selective use
    98 strategies
    99 study
    100 technology
    101 test
    102 third scenario
    103 threshold
    104 total direct costs
    105 total requirement
    106 treatment
    107 treatment of osteoporosis
    108 use
    109 women
    110 years
    111 schema:name Requirements for DXA for the management of osteoporosis in Europe
    112 schema:pagination 229-238
    113 schema:productId N0a3fb6d0c6164e72afef12d646733cea
    114 N323a3adbaab14f20b0105f83aa253a7f
    115 N40274b8c4e744ca0a7a9e003628e94ad
    116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033148553
    117 https://doi.org/10.1007/s00198-004-1811-2
    118 schema:sdDatePublished 2022-05-20T07:22
    119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    120 schema:sdPublisher N2ac022d8bbfa42ae9f59bfd7d6223efc
    121 schema:url https://doi.org/10.1007/s00198-004-1811-2
    122 sgo:license sg:explorer/license/
    123 sgo:sdDataset articles
    124 rdf:type schema:ScholarlyArticle
    125 N0a3fb6d0c6164e72afef12d646733cea schema:name dimensions_id
    126 schema:value pub.1033148553
    127 rdf:type schema:PropertyValue
    128 N0dd6a5f1212d4ef89b645305379b4b7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Cost-Benefit Analysis
    130 rdf:type schema:DefinedTerm
    131 N0f86bfe3513d49048f87a947dcc77062 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Europe
    133 rdf:type schema:DefinedTerm
    134 N1ac92e67f401422ea98eb9008240796c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Osteoporosis
    136 rdf:type schema:DefinedTerm
    137 N2ac022d8bbfa42ae9f59bfd7d6223efc schema:name Springer Nature - SN SciGraph project
    138 rdf:type schema:Organization
    139 N2ac417c8c0694b709b3e6719561c0b14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Male
    141 rdf:type schema:DefinedTerm
    142 N323a3adbaab14f20b0105f83aa253a7f schema:name pubmed_id
    143 schema:value 15618996
    144 rdf:type schema:PropertyValue
    145 N343fc081b70740ad97789dabb7fc8867 schema:issueNumber 3
    146 rdf:type schema:PublicationIssue
    147 N3d778d3b5a09491988c8a516fcb9cc63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Age Distribution
    149 rdf:type schema:DefinedTerm
    150 N40274b8c4e744ca0a7a9e003628e94ad schema:name doi
    151 schema:value 10.1007/s00198-004-1811-2
    152 rdf:type schema:PropertyValue
    153 N56a7ffa941a1458b8749731f7e201d80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Aged
    155 rdf:type schema:DefinedTerm
    156 N65bc4aeff20e489dae590225bcc63f84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Risk Factors
    158 rdf:type schema:DefinedTerm
    159 N6c0bdf54e9cb41f6bd59fb77b2588be0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Hip Fractures
    161 rdf:type schema:DefinedTerm
    162 N6c58d8d179874a4d94a4b2ca912b5d99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Sex Distribution
    164 rdf:type schema:DefinedTerm
    165 N7aa9963c1a984254ac8f732dd211d5fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Female
    167 rdf:type schema:DefinedTerm
    168 N9d1c99ac43404ddebe0a61d2b2aeb152 rdf:first sg:person.01045771226.52
    169 rdf:rest rdf:nil
    170 Na5df5f249b88477dad9613fa5bfe88e6 rdf:first sg:person.0663427426.32
    171 rdf:rest N9d1c99ac43404ddebe0a61d2b2aeb152
    172 Nb0bfbfc5a9d1443095bc15a9493c0600 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Osteoporosis, Postmenopausal
    174 rdf:type schema:DefinedTerm
    175 Nd6a711a8ad3d4aaeab487b1e5f7d505a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Absorptiometry, Photon
    177 rdf:type schema:DefinedTerm
    178 Nd73016a883644eee9d0ecb4607c3ee48 schema:volumeNumber 16
    179 rdf:type schema:PublicationVolume
    180 Ndae2714d33ac4d72b9c66732524d7404 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Bone Density
    182 rdf:type schema:DefinedTerm
    183 Ndca4bba4df1b44b88964500acf6d7490 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Mass Screening
    185 rdf:type schema:DefinedTerm
    186 Nf10306a0e1a74fa8aa03292bf6066786 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Patient Selection
    188 rdf:type schema:DefinedTerm
    189 Nf3948982199e436ea893721a1619d158 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Humans
    191 rdf:type schema:DefinedTerm
    192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    193 schema:name Medical and Health Sciences
    194 rdf:type schema:DefinedTerm
    195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    196 schema:name Clinical Sciences
    197 rdf:type schema:DefinedTerm
    198 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    199 schema:name Public Health and Health Services
    200 rdf:type schema:DefinedTerm
    201 sg:journal.1100834 schema:issn 0937-941X
    202 1433-2965
    203 schema:name Osteoporosis International
    204 schema:publisher Springer Nature
    205 rdf:type schema:Periodical
    206 sg:person.01045771226.52 schema:affiliation grid-institutes:grid.411843.b
    207 schema:familyName Johnell
    208 schema:givenName O.
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045771226.52
    210 rdf:type schema:Person
    211 sg:person.0663427426.32 schema:affiliation grid-institutes:grid.11835.3e
    212 schema:familyName Kanis
    213 schema:givenName J. A.
    214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663427426.32
    215 rdf:type schema:Person
    216 sg:pub.10.1007/bf01623186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017480562
    217 https://doi.org/10.1007/bf01623186
    218 rdf:type schema:CreativeWork
    219 sg:pub.10.1007/bf01623349 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002170955
    220 https://doi.org/10.1007/bf01623349
    221 rdf:type schema:CreativeWork
    222 sg:pub.10.1007/bf01623689 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019441113
    223 https://doi.org/10.1007/bf01623689
    224 rdf:type schema:CreativeWork
    225 sg:pub.10.1007/bf01623782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015221140
    226 https://doi.org/10.1007/bf01623782
    227 rdf:type schema:CreativeWork
    228 sg:pub.10.1007/pl00004148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016444239
    229 https://doi.org/10.1007/pl00004148
    230 rdf:type schema:CreativeWork
    231 sg:pub.10.1007/s00198-003-1385-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020641858
    232 https://doi.org/10.1007/s00198-003-1385-4
    233 rdf:type schema:CreativeWork
    234 sg:pub.10.1007/s00198-003-1395-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016850751
    235 https://doi.org/10.1007/s00198-003-1395-2
    236 rdf:type schema:CreativeWork
    237 sg:pub.10.1007/s00198-003-1463-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049023520
    238 https://doi.org/10.1007/s00198-003-1463-7
    239 rdf:type schema:CreativeWork
    240 sg:pub.10.1007/s00198-003-1500-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024649739
    241 https://doi.org/10.1007/s00198-003-1500-6
    242 rdf:type schema:CreativeWork
    243 sg:pub.10.1007/s00198-003-1544-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029733134
    244 https://doi.org/10.1007/s00198-003-1544-7
    245 rdf:type schema:CreativeWork
    246 sg:pub.10.1007/s00198-004-1605-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009573377
    247 https://doi.org/10.1007/s00198-004-1605-6
    248 rdf:type schema:CreativeWork
    249 sg:pub.10.1007/s00198-004-1623-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048606247
    250 https://doi.org/10.1007/s00198-004-1623-4
    251 rdf:type schema:CreativeWork
    252 sg:pub.10.1007/s00198-004-1686-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016570955
    253 https://doi.org/10.1007/s00198-004-1686-2
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1007/s001980050107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004873970
    256 https://doi.org/10.1007/s001980050107
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1007/s001980050113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027556556
    259 https://doi.org/10.1007/s001980050113
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1007/s001980050281 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008829241
    262 https://doi.org/10.1007/s001980050281
    263 rdf:type schema:CreativeWork
    264 sg:pub.10.1007/s001980070064 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042388661
    265 https://doi.org/10.1007/s001980070064
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1007/s001980170112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037984736
    268 https://doi.org/10.1007/s001980170112
    269 rdf:type schema:CreativeWork
    270 grid-institutes:grid.11835.3e schema:alternateName WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK
    271 schema:name WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK
    272 rdf:type schema:Organization
    273 grid-institutes:grid.411843.b schema:alternateName Department of Orthopaedics, Malmo General Hospital, S-214 01, Malmo, Sweden
    274 schema:name Department of Orthopaedics, Malmo General Hospital, S-214 01, Malmo, Sweden
    275 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...